Department of Pathology, University of Southern California, Los Angeles, CA 90033;
The Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90033.
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11309-11318. doi: 10.1073/pnas.1818820116. Epub 2019 May 16.
The mitotic protein polo-like kinase 4 (PLK4) plays a critical role in centrosome duplication for cell division. By using immunofluorescence, we confirm that PLK4 is localized to centrosomes. In addition, we find that phospho-PLK4 (pPLK4) is cleaved and distributed to kinetochores (metaphase and anaphase), spindle midzone/cleavage furrow (anaphase and telophase), and midbody (cytokinesis) during cell division in immortalized epithelial cells as well as breast, ovarian, and colorectal cancer cells. The distribution of pPLK4 midzone/cleavage furrow and midbody positions pPLK4 to play a functional role in cytokinesis. Indeed, we found that inhibition of PLK4 kinase activity with a small-molecule inhibitor, CFI-400945, prevents translocation to the spindle midzone/cleavage furrow and prevents cellular abscission, leading to the generation of cells with polyploidy, increased numbers of duplicated centrosomes, and vulnerability to anaphase or mitotic catastrophe. The regulatory role of PLK4 in cytokinesis makes it a potential target for therapeutic intervention in appropriately selected cancers.
有丝分裂蛋白 polo 样激酶 4(PLK4)在细胞分裂的中心体复制中起着关键作用。通过免疫荧光,我们证实 PLK4 定位于中心体。此外,我们发现磷酸化 PLK4(pPLK4)在永生化上皮细胞以及乳腺癌、卵巢癌和结直肠癌细胞的有丝分裂过程中被切割并分布到着丝粒(中期和后期)、纺锤体中部/分裂沟(后期和末期)和中体(胞质分裂)。pPLK4 在中部/分裂沟和中体的分布将 pPLK4 定位为在胞质分裂中发挥功能作用。事实上,我们发现用小分子抑制剂 CFI-400945 抑制 PLK4 激酶活性可阻止其向纺锤体中部/分裂沟的转移,并防止细胞分离,导致多倍体细胞的产生、复制中心体数量增加以及对后期或有丝分裂灾难的易感性。PLK4 在胞质分裂中的调节作用使其成为在适当选择的癌症中进行治疗干预的潜在靶点。